China hits pharma company with major fine
China’s competition watchdog has fined a major pharmaceutical group about €97.6 million for fixing the resale price of multiple drugs over a four year period.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.